HomeNBSE • BMV
add
NeuBase Therapeutics Ord Shs
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 33.32M | 25.42% |
Net income | -33.78M | -32.93% |
Net profit margin | — | — |
Earnings per share | -20.80 | -11.83% |
EBITDA | -32.55M | -24.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 23.15M | -56.23% |
Total assets | 32.69M | -49.05% |
Total liabilities | 9.50M | -5.90% |
Total equity | 23.19M | — |
Shares outstanding | 1.65M | — |
Price to book | 3.66 | — |
Return on assets | -43.00% | — |
Return on capital | -46.38% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -33.78M | -32.93% |
Cash from operations | -29.01M | -53.72% |
Cash from investing | -471.74K | 81.60% |
Cash from financing | -257.02K | -100.61% |
Net change in cash | -29.74M | -242.29% |
Free cash flow | -16.66M | -15.19% |
About
Founded
2009
Website
Employees
37
